000			01911 a2200541 4500
005			20250514075743.0
264		0	_c20040519
008			200405s 0 0 eng d
022			_a1538-7933
024	7		_a10.1046/j.1538-7836.2003.00351.x _2doi
040			_aNLM _beng _cNLM
100	1		_aVogel, G M T
245	0	0	_aAntithrombotic properties of a direct thrombin inhibitor with a prolonged half-life and AT-mediated factor Xa inhibitory activity. _h[electronic resource]
260			_bJournal of thrombosis and haemostasis : JTH _cSep 2003
300			_a1945-54 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAnimals
650	0	4	_aAntithrombin III _xphysiology
650	0	4	_aArginine _xanalogs & derivatives
650	0	4	_aBlood Coagulation Tests
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aFactor Xa Inhibitors
650	0	4	_aFibrinolytic Agents _xpharmacokinetics
650	0	4	_aFondaparinux
650	0	4	_aHalf-Life
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHeparin _xpharmacology
650	0	4	_aMale
650	0	4	_aMolecular Structure
650	0	4	_aOligosaccharides _xpharmacokinetics
650	0	4	_aPipecolic Acids _xpharmacology
650	0	4	_aPolysaccharides _xpharmacology
650	0	4	_aRabbits
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aSulfonamides
650	0	4	_aThrombin _xantagonists & inhibitors
650	0	4	_aThrombolytic Therapy _xmethods
650	0	4	_aThrombosis _xdrug therapy
700	1		_aMeuleman, D G
700	1		_aVan Dinther, T G
700	1		_aBuijsman, R
700	1		_aPrincen, A W M
700	1		_aSmit, M J
773	0		_tJournal of thrombosis and haemostasis : JTH _gvol. 1 _gno. 9 _gp. 1945-54
856	4	0	_uhttps://doi.org/10.1046/j.1538-7836.2003.00351.x _zAvailable from publisher's website
999			_c12711134 _d12711134